Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis.

[1]  R. Blankstein,et al.  Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization , 2015, Circulation.

[2]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.

[4]  O. Rimoldi,et al.  Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.

[5]  P. Damman,et al.  Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity , 2014, Circulation. Cardiovascular interventions.

[6]  B. Ibáñez,et al.  Disturbed Coronary Hemodynamics in Vessels With Intermediate Stenoses Evaluated With Fractional Flow Reserve: A Combined Analysis of Epicardial and Microcirculatory Involvement in Ischemic Heart Disease , 2013, Circulation.

[7]  Seung‐Jung Park,et al.  Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice. , 2013, European heart journal.

[8]  P. Damman,et al.  Impaired Coronary Autoregulation Is Associated With Long-term Fatal Events in Patients With Stable Coronary Artery Disease , 2013, Circulation. Cardiovascular interventions.

[9]  P. Ridker,et al.  Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. , 2013, JACC. Cardiovascular imaging.

[10]  P. Damman,et al.  Impact of Coronary Microvascular Function on Long-term Cardiac Mortality in Patients With Acute ST-Segment–Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.

[11]  Jing Li,et al.  Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. , 2013, European heart journal.

[12]  Michael C. McDaniel,et al.  Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. , 2012, Atherosclerosis.

[13]  K. Gould,et al.  Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. , 2012, JACC. Cardiovascular imaging.

[14]  O. Rimoldi,et al.  The coronary circulation and blood flow in left ventricular hypertrophy. , 2012, Journal of molecular and cellular cardiology.

[15]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[16]  R. Kirkeeide,et al.  Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? , 2012, JACC. Cardiovascular imaging.

[17]  G. Levine,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[18]  U. Siebert,et al.  Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .

[19]  F. Crea,et al.  Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management , 2010, Circulation.

[20]  G. Heinze,et al.  Avoiding infinite estimates of time‐dependent effects in small‐sample survival studies , 2008, Statistics in medicine.

[21]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[22]  J. Tijssen,et al.  The prognostic value of combined intracoronary pressure and blood flow velocity measurements after deferral of percutaneous coronary intervention , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  G. Taffet,et al.  Coronary Microvascular Dysfunction , 2007 .

[24]  A. Yeung,et al.  Invasive Assessment of the Coronary Microcirculation: Superior Reproducibility and Less Hemodynamic Dependence of Index of Microcirculatory Resistance Compared With Coronary Flow Reserve , 2006, Circulation.

[25]  V. Klauss,et al.  Validation of coronary flow reserve measurements by thermodilution in clinical practice. , 2004, European heart journal.

[26]  K. Berhane,et al.  Inference in Spline‐Based Models for Multiple Time‐to‐Event Data, with Applications to a Breast Cancer Prevention Trial , 2003, Biometrics.

[27]  A. Yeung,et al.  Comparison of Coronary Thermodilution and Doppler Velocity for Assessing Coronary Flow Reserve , 2003, Circulation.

[28]  M Schemper,et al.  A Solution to the Problem of Monotone Likelihood in Cox Regression , 2001, Biometrics.

[29]  G. Gensini,et al.  A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.

[30]  F. Crea,et al.  Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .

[31]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[32]  R. Whitbourn,et al.  Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. , 2013, JACC. Cardiovascular interventions.

[33]  G. Levine,et al.  ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions , 2011 .

[34]  G. Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2009 .

[35]  : Clinical Original Research Put Into Perspective for the Practicing Clinician Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease , 2022 .